27 insiders reported 28 Form 4 transactions for ACTUATE THERAPEUTICS, INC. (ACTU) over the past 18 months (most recent 2026-02-13). Recent activity: SCHMITT DANIEL M (President, CEO and Director) Buy 272,055 shares, SCHMITT DANIEL M (President, CEO and Director) Sell 121,874 shares, THOMSON TODD S (Director) Sell 280,000 shares, Kairos Venture Partners II, L.P. (Director) Sell 280,000 shares, BIOS Advisors GP, LLC (Director) Buy 71,428 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | SCHMITT DANIEL M | President, CEO and Director | Buy | 272,055 | $0 |
| 2026-02-13 | SCHMITT DANIEL M | President, CEO and Director | Sell | 121,874 | $527,714 |
| 2026-01-07 | THOMSON TODD S | Director | Sell | 280,000 | $1.6M |
| 2026-01-07 | Kairos Venture Partners II, L.P. | Director | Sell | 280,000 | $1.6M |
| 2025-06-30 | BIOS Advisors GP, LLC | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BP Directors, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Bios Clinical Opportunity Fund, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Bios Equity COF, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Actuate Co-Invest I, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III NT, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III QP, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Bios 2024 Co-Invest, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Cavu Advisors, LLC | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Capital Management, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Actuate Co-Invest II, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Equity Partners III, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Bios Actuate Co-Invest III, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Fletcher Aaron G.L. | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund I QP, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II QP, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund II NT, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund I, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | Cavu Management, LP | Director | Buy | 71,428 | $499,996 |
| 2025-06-30 | BIOS Fund III, LP | Director | Buy | 71,428 | $499,996 |
Source: SEC Form 4 filings · as of 2026-02-13
